AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended December 31, 202214-02-2023
14-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Financial Results For The Quarter Ended December 31, 2022
Financial Results for the Quarter Ended December 31, 202214-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Outcome for Outcome Of The Board Meeting
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (February 14, 2023) had inter-alia: (i) Approved the Un-Audited Financial Results for the quarter ended December 31, 2022. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared Second Interim Dividend of Re.1/- per share for the financial year 2022-23 on the Equity Shares of the Company.14-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Initiation Of Forensic Investigation Of Our Company, Amrutanjan Health Care Limited
Pursuant to the above-mentioned regulation, this is to keep you informed that the Company has received an anonymous whistle blower complaint alleging lapses by certain senior management employees including undue enrichment through marketing, advertising and procurement activities, ethical concerns, and conflict of interest etc. The Company has initiated a forensic investigation by Deloitte Touche Tohmatsu India LLP (forensic auditors) in respect of the above allegations. The Company shall extend its fullest cooperation and information to the forensic auditors during the process of the investigation as per applicable provisions of law. The Company shall also file the final report of forensic audit with comments of the management, if any, as per regulations.14-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation is hereby given that the Company has received a request from the below-mentioned shareholder for issuance of Duplicate Share Certificate consequent to loss of original Share Certificate. We request you to note that the Company/RTA is processing the request for issuing the said duplicate share certificate and will issue the same within the stipulated time period.10-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Intimation Under Regulation 42 Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 (SEBI LODR)
Pursuant to regulation 42 of SEBI LODR, we wish to inform that the Company has fixed 24th February 2023 as record date for payment of Second Interim Dividend for the financial year 2022-23, if approved, to members whose name appear in the register of Members and as the beneficial owners as per the details received from National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) as on the record date. We request to take the above on record and acknowledge the receipt.07-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Intimation for Board To Consider Un-Audited Financial Results Along With The Limited Review Report For The Quarter Ended December 31, 2022 And Declaration Of 2Nd Interim Dividend For The Financial Year 2022-23
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve Pursuant to the above mentioned regulation of SEBI LODR, we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday, the 14th February, 2023 thru Video Conferencing to consider and approve, inter-alia, the: a) Un-Audited Financial Results along with the Limited Review Report for the quarter ended December 31, 2022. b) Declaration of 2nd Interim Dividend for the financial year 2022-23 Request to take the above on record and acknowledge.07-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others07-02-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate u/r 74 (5) of SEBI (DP) Regulations, 201819-01-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201513-01-2023